171 related articles for article (PubMed ID: 8815280)
1. [Serum neopterin in Behçet's disease].
Samsonov MIu; Prokaeva TB; Madanat V; Alekberova ZS; Nasonov EL; Fuks D; Vakhter Kh
Klin Med (Mosk); 1995; 73(5):53-5. PubMed ID: 8815280
[TBL] [Abstract][Full Text] [Related]
2. Is there any relationship between serum and urine neopterin and serum interferon-gamma levels in the activity of Behcet's disease?
Erturan I; Basak PY; Ozturk O; Ceyhan AM; Akkaya VB
J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1414-8. PubMed ID: 19522774
[TBL] [Abstract][Full Text] [Related]
3. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
4. Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease.
Ozkan Y; Yardim-Akaydin S; Sepici A; Engin B; Sepici V; Simşek B
Clin Chem Lab Med; 2007; 45(1):73-7. PubMed ID: 17243919
[TBL] [Abstract][Full Text] [Related]
5. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
6. [Serum neopterin in hemorrhagic vasculitis].
Baranov AA; Samsonov MI; Nasonov EL; Vachter H; Shilkina NP; Fuchs D; Salozhin KV
Klin Med (Mosk); 1997; 75(6):34-6. PubMed ID: 9273397
[TBL] [Abstract][Full Text] [Related]
7. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine: an activity marker in Behçet's disease?
Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
[TBL] [Abstract][Full Text] [Related]
9. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
10. Serum oxidant/antioxidant status in patients with Behçet's disease.
Taysi S; Kocer I; Memisogullari R; Kiziltunc A
Ann Clin Lab Sci; 2002; 32(4):377-82. PubMed ID: 12458889
[TBL] [Abstract][Full Text] [Related]
11. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis.
Nassonov EL; Samsonov MY; Tilz GP; Beketova TV; Semenkova EN; Baranov A; Wachter H; Fuchs D
J Rheumatol; 1997 Apr; 24(4):666-70. PubMed ID: 9101499
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of serum and urinary neopterin levels in patients with various liver diseases.
Daito K; Suou T; Kawasaki H
Am J Gastroenterol; 1992 Apr; 87(4):471-6. PubMed ID: 1313206
[TBL] [Abstract][Full Text] [Related]
14. [Serum neopterin in hepatitis B].
Samsonov MIu; Golban TD; Nasonov EL; Masenko VP
Klin Med (Mosk); 1992; 70(3-4):40-2. PubMed ID: 1507845
[TBL] [Abstract][Full Text] [Related]
15. Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease.
Akar S; Ozcan MA; Ateş H; Gürler O; Alacacioglu I; Ozsan GH; Akkoç N; Ozkan S; Demirkan F; Onen F
Clin Appl Thromb Hemost; 2006 Oct; 12(4):451-7. PubMed ID: 17000890
[TBL] [Abstract][Full Text] [Related]
16. Increased serum ferritin levels in active Behçet's disease.
Odabas AR; Karakuzu A; Cetinkaya R; Selcuk Y; Keles S; Bilen H
Int J Clin Pract; 2002 May; 56(4):310-1. PubMed ID: 12074217
[TBL] [Abstract][Full Text] [Related]
17. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
[TBL] [Abstract][Full Text] [Related]
18. [The level of neopterin in the plasma of patients with acute kidney failure during treatment with continuous arteriovenous hemofiltration].
Timokhov VS; Kazakov IV; Toritsina LK; Ipat'eva EI; Ametov AS
Urol Nefrol (Mosk); 1991; (3):53-7. PubMed ID: 1871925
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of postmortem serum concentrations of neopterin and C-reactive protein.
Ishikawa T; Hamel M; Zhu BL; Li DR; Zhao D; Michiue T; Maeda H
Forensic Sci Int; 2008 Aug; 179(2-3):135-43. PubMed ID: 18541395
[TBL] [Abstract][Full Text] [Related]
20. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity.
Aki T; Karincaoglu Y; Seyhan M; Batcioglu K
Clin Exp Dermatol; 2006 Jul; 31(4):583-7. PubMed ID: 16716167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]